Enorama Pharma (Sweden) Technical Analysis
| ERMA Stock | SEK 3.76 0.13 3.34% |
As of the 27th of November, Enorama Pharma shows the Mean Deviation of 4.16, standard deviation of 5.51, and Variance of 30.33. Enorama Pharma AB technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Enorama Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Enorama, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EnoramaEnorama |
Enorama Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Enorama Pharma AB Technical Analysis
The output start index for this execution was four with a total number of output elements of fifty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Enorama Pharma AB volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Enorama Pharma AB Trend Analysis
Use this graph to draw trend lines for Enorama Pharma AB. You can use it to identify possible trend reversals for Enorama Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Enorama Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Enorama Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Enorama Pharma AB applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Enorama Pharma AB market price will keep on failing further. It has 122 observation points and a regression sum of squares at 12.1, which is the sum of squared deviations for the predicted Enorama Pharma price change compared to its average price change.About Enorama Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Enorama Pharma AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Enorama Pharma AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Enorama Pharma AB price pattern first instead of the macroeconomic environment surrounding Enorama Pharma AB. By analyzing Enorama Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Enorama Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Enorama Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Enorama Pharma November 27, 2024 Technical Indicators
Most technical analysis of Enorama help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Enorama from various momentum indicators to cycle indicators. When you analyze Enorama charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 1.99 | |||
| Mean Deviation | 4.16 | |||
| Coefficient Of Variation | (1,442) | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.33 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | 1.98 | |||
| Maximum Drawdown | 27.06 | |||
| Value At Risk | (8.91) | |||
| Potential Upside | 10.4 | |||
| Skewness | 0.4402 | |||
| Kurtosis | 0.4735 |
Additional Tools for Enorama Stock Analysis
When running Enorama Pharma's price analysis, check to measure Enorama Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enorama Pharma is operating at the current time. Most of Enorama Pharma's value examination focuses on studying past and present price action to predict the probability of Enorama Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enorama Pharma's price. Additionally, you may evaluate how the addition of Enorama Pharma to your portfolios can decrease your overall portfolio volatility.